89 results
Type of content
News Remove News filter
Responsible body
CVMP Remove CVMP filter
CHMP Remove CHMP filter
PRAC Remove PRAC filter
CMDh Remove CMDh filter
Patient safety
Yes Remove Yes filter
-
List item
Press release: Leuprorelin depot medicines: PRAC recommends new measures to avoid handling errors
PRAC, Last updated: 15/05/2020 -
List item
Press release: EMA recommendations on DPD testing prior to treatment with fluorouracil, capecitabine, tegafur and flucytosine
CHMP, Last updated: 30/04/2020 -
List item
Press release: Risks of Picato for actinic keratosis outweigh benefits
CHMP, Last updated: 30/04/2020 -
List item
Press release: Suspension of ranitidine medicines in the EU
CHMP, Last updated: 30/04/2020 -
List item
Press release: EMA review of Picato concludes medicine’s risks outweigh its benefits
PRAC, Last updated: 17/04/2020 -
List item
Press release: Restrictions in use of cyproterone due to meningioma risk
CMDh, Last updated: 27/03/2020 -
List item
Press release: No change is needed in use of direct oral anticoagulants following EMA-funded study
CHMP, Last updated: 27/03/2020 -
List item
Press release: Recommendations to restrict use of fosfomycin antibiotics
CHMP, Last updated: 27/03/2020 -
List item
Press release: Benefits of medicines containing combination of methocarbamol and paracetamol continue to outweigh risks
CHMP, Last updated: 27/03/2020 -
List item
Press release: Suspension of ulipristal acetate for uterine fibroids during ongoing EMA review of liver injury risk
PRAC, Last updated: 13/03/2020 -
List item
Press release: Restrictions in use of cyproterone due to meningioma risk
PRAC, Last updated: 14/02/2020 -
List item
Press release: EMA suspends Picato as a precaution while review of skin cancer risk continues
PRAC, Last updated: 17/01/2020 -
List item
Press release: PRAC confirms four-week limit for use of high-strength estradiol creams
PRAC, Last updated: 17/01/2020 -
List item
Press release: EMA confirms Xeljanz to be used with caution in patients at high risk of blood clots
CHMP, Last updated: 15/11/2019 -
List item
Press release: Measures to minimise risk of serious side effects of multiple sclerosis medicine Lemtrada
CHMP, Last updated: 15/11/2019 -
List item
Press release: Four-week limit for use of high-strength estradiol creams
PRAC, Last updated: 04/10/2019 -
List item
Press release: New measures to avoid potentially fatal dosing errors with methotrexate for inflammatory diseases
CHMP, Last updated: 23/08/2019 -
List item
Press release: PRAC recommends new measures to avoid dosing errors with methotrexate
PRAC, Last updated: 12/07/2019 -
List item
Press release: Withdrawal of marketing authorisations for fenspiride medicines
PRAC, Last updated: 17/05/2019 -
List item
Press release: Restrictions in use of Xeljanz while EMA reviews risk of blood clots in lungs
PRAC, Last updated: 17/05/2019 -
List item
Press release: Use of multiple sclerosis medicine Lemtrada restricted while EMA review is ongoing
PRAC, Last updated: 12/04/2019 -
List item
Press release: Increased risk of blood clots in lungs and death with higher dose of Xeljanz (tofacitinib) for rheumatoid arthritis
CHMP, Last updated: 20/03/2019 -
List item
Press release: Suspension of fenspiride medicines due to potential risk of heart rhythm problems
PRAC, Last updated: 15/02/2019 -
List item
Press release: Sartan medicines: companies to review manufacturing processes to avoid presence of nitrosamine impurities
CHMP, Last updated: 01/02/2019 -
List item
Press release: No new patients should start treatment with Lartruvo after study shows cancer medicine does not prolong life
CHMP, Last updated: 23/01/2019